We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+12.56%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$209M
AUM Growth
-$297M
Cap. Flow
-$320M
Cap. Flow %
-153.37%
Top 10 Hldgs %
65.08%
Holding
109
New
15
Increased
55
Reduced
7
Closed
24

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.02M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$1.71M
3
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$961K
4
COR icon
Cencora
COR
+$771K
5
UBER icon
Uber
UBER
+$363K

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$6.06M
2
MS icon
Morgan Stanley
MS
+$4.73M
3
CISN
Cision Ltd. Ordinary Share
CISN
+$4.61M
4
AGN
Allergan plc
AGN
+$3.37M
5
WBD icon
Warner Bros
WBD
+$1.51M

Sector Composition

Rank Sector Weight
1 Healthcare 35.46%
2 Financials 23.37%
3 Communication Services 14.38%
4 Technology 7.7%
5 Industrials 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATH
1
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$26.1M 12.48%
553,921
– –
MS icon
2
Morgan Stanley
MS
$339B
$17.1M 8.2%
334,846
-99,990
-23% -$4.73M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.22T
$15.4M 7.37%
230,000
– –
CVS icon
4
CVS Health
CVS
$137B
$13.3M 6.37%
178,791
-14,297
-7% -$1M
ZBH icon
5
Zimmer Biomet
ZBH
$17.6B
$11.7M 5.62%
80,773
-6,606
-8% -$912K
DAL icon
6
Delta Air Lines
DAL
$55.4B
$11.7M 5.6%
200,000
– –
COR icon
7
Cencora
COR
$59.9B
$11.4M 5.46%
134,000
+9,000
+7% +$771K
FOMX
8
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$11.2M 5.37%
3,365,000
+302,407
+10% +$961K
DVA icon
9
DaVita
DVA
$15.2B
$9.75M 4.67%
130,000
-20,000
-13% -$1.33M
WBD icon
10
Warner Bros
WBD
$67.4B
$8.19M 3.92%
250,000
-50,000
-17% -$1.51M
ACEL icon
11
Accel Entertainment
ACEL
$989M
$8.13M 3.89%
650,000
-29,275
-4% -$318K
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
$7.41M 3.55%
68,500
+16,000
+30% +$1.71M
NIO icon
13
PUT
NIO
NIO
$12.2B
$4.81M 2.31%
+1,196,900
New +$2.41M
BMY icon
14
Bristol-Myers Squibb
BMY
$124B
$4.57M 2.19%
71,239
+70,156
+6,478% +$4.02M
CVS icon
15
CALL
CVS Health
CVS
$137B
$4.53M 2.17%
61,000
+25,000
+69% +$1.76M
MSFT icon
16
Microsoft
MSFT
$2.93T
$2.26M 1.08%
14,318
+1,544
+12% +$227K
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$4.23T
$2.23M 1.07%
33,240
+4,820
+17% +$311K
META icon
18
Meta Platforms (Facebook)
META
$1.64T
$1.92M 0.92%
9,341
+1,367
+17% +$265K
V icon
19
Visa
V
$682B
$1.75M 0.84%
9,317
+1,757
+23% +$317K
MA icon
20
Mastercard
MA
$480B
$1.72M 0.82%
5,753
+1,027
+22% +$290K
SLV icon
21
CALL
iShares Silver Trust
SLV
$27.1B
$1.67M 0.8%
100,000
– –
ADBE icon
22
Adobe
ADBE
$94.3B
$1.62M 0.78%
4,908
+867
+21% +$255K
ZVRA icon
23
Zevra Therapeutics
ZVRA
$755M
$1.55M 0.74%
255,995
– –
ACN icon
24
Accenture
ACN
$87.9B
$1.54M 0.74%
7,326
+1,588
+28% +$310K
AAPL icon
25
Apple
AAPL
$4.9T
$1.52M 0.73%
20,768
-20
-0.1% -$1.29K
1
2 3 4 5

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, DSC Advisors held 109 positions worth $209M, down 59% from $506M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

DSC Advisors withdrew a net $320M in Q4 2019, closing 24 positions and reducing 7 holdings. Its most notable exit was Paramount Global Class B, an estimated $6.06M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

Against the trend, DSC Advisors opened a new position in Uber worth $364K.

  • DSC Advisors's largest Q4 2019 buy was Uber: 12,240 shares worth $364K.
  • DSC Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $4.02M increase.
  • DSC Advisors's biggest Q4 2019 reduction was Morgan Stanley, cutting an estimated $4.73M.
  • DSC Advisors fully exited Paramount Global Class B in Q4 2019, selling an estimated $6.06M.
  • DSC Advisors's ten largest holdings make up 65% of its $209M portfolio in Q4 2019.
  • DSC Advisors opened 15 new positions and closed 24 in Q4 2019.
  • DSC Advisors's portfolio value fell 59% quarter-over-quarter to $209M.

Based on DSC Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.